Global Personalized Cell Therapy Market Trends, Analysis, Growth, and Forecast: 2018 to 2027
-
4043
-
May 2023
-
155
-
-
This report was compiled by Correspondence Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Global Personalized Cell Therapy Market Overview:
“The global Personalized Cell Therapy Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”
Personalized cell therapy helps to determine every person’s unique diseases susceptibility and further determines preventive measures to the treatment of diseases. It provides earlier diagnosis of disease, risk assessments, optimal treatments and also improves health condition while lowering the cost of the treatment. Personalized cell therapy are developed for niche indications or conditions with high unmet need. Ongoing research on development of personized cell therapy for diabetes is expected to augment the market growth over the forecast period.
Increasing number of cases of chronic diseases such as diabetics, neurological disorders, and diabetes is one of the major factor expected to boost the growth of global personalized cell therapy market over the forecast period. In addition, rising government funding for research and development for stem cell research is major factors expected to drive the growth of global personalized cell therapy market over the forecast period. Introduction of innovative techniques and procedure by players in the market is expected to create demand for personalized cell therapy which in turn is expected to propel the market growth.
Continuous innovations by manufacturers to develop agents that are targeted to patient groups which does not respond to medications or traditional treatment is expected to create new opportunities for existing players and new entrant in the global personalized cell therapy market over the forecast period. Cell therapy technologies drive growth in the Personalized Cell Therapy Market, tailoring treatments to individual patients for precision medicine.
North America market dominates the global personalized cell therapy market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to presence of well-developed healthcare infrastructure and high adoption of advance techniques for treatment of diseases in the region. Europe accounts for second-largest revenue share contribution to the global personalized cell therapy market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to the developing healthcare infrastructure, rising awareness regarding the benefits associated with personalized cell therapies in the region.
Global Personalized Cell Therapy Market Segmentation:
Global personalized cell therapy market segmentation, by technique:
- Platelet Transfusions
- Bone Marrow Transplantation
- Packed Red Cell Transfusions
- Organ Transplantation
Global personalized cell therapy market segmentation, by therapeutic area:
- Cardiovascular Diseases
- Neurological Disorders
- Inflammatory Diseases
- Diabetes
- Cancer
Global personalized cell therapy market segmentation, by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
-
- Cytori Therapeutics Inc.
- Bellicum Pharmaceuticals, Inc.
- Saneron CCEL Therapeutics, Inc.
- MolMed S.p.A.
- Vericel Corporation
- Oxford Nanopore Technologies
- Cell Medica
- MediGene AG
- TxCell
Our Clients
View Our Licence Options
